Deutsch English Français

Contact

EP1615913

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1615913

EP1615913 - PROCESS FOR PREPARING 2-(PYRIDINYL)METHYL SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 21.05.2010 Database last updated on 21.05.2024
Most recent event Tooltip	21.05.2010	Application deemed to be withdrawn	published on 23.06.2010 [2010/25]
Applicant(s)	For all designated states Teva Pharmaceutical Industries Limited 5 Basel Street, Box 3190 Petah Tikvah 49131 / IL
	[2006/03]
Inventor(s)	01 / LIBERMAN, Anita 14 Michael Neaman Tel-Aviv, Israel / IL
	02 / SINGER, Claude 8/8 David Elazar Kfar Saba 44358 / IL
	03 / RAIZI, Yuriy 34, Rishon le Zion Str. Natanya 42374 / IL
	04 / PILARSKY; Gideon 12/29 Atoroth 58487 Holon / IL
	05 / BRAUDE, Viviana 18 Hanevel Street 60920 Kadima / IL
	06 / FINKELSTEIN, Nina Katzenelson Street 23B/17 46290 Herzliya / IL
	07 / CHEN, Kobi 21 Beit Hilel Street 47291 Ramat HaSharon / IL
	[2006/17]
Former [2006/03]	01 / LIBERMAN, Anita Rechov Ben-Joseph 28 Tel-Aviv, Israel / IL
	02 / SINGER, Claude 8/8 David Elazar Kfar Saba 44358 / IL
	03 / RAIZI, Yuriy 34, Rishon le Zion Str. Natanya 42374 / IL
	04 / PILARSKY; Gideon 12/29 Atoroth 58487 Holon / IL
	05 / BRAUDE, Viviana 18 Hanevel Street 60920 Kadima / IL
	06 / FINKELSTEIN, Nina Katzenelson Street 23B/17 46290 Herzliya / IL
	07 / CHEN, Kobi 21 Beit Hilel Street 47291 Ramat HaSharon / IL
Representative(s)	Gallagher, Kirk James, et al D Young & Co LLP 120 Holborn London EC1N 2DY / GB
	[N/P]
Former [2006/03]	Gallagher, Kirk James, et al D Young & Co 120 Holborn London EC1N 2DY / GB
Application number, filing date	04755278.1	10.06.2004
	[2006/03]
	WO2004US19001
Priority number, date	US20030477045P	10.06.2003 Original published format: US 477045 P
	US20030525851P	01.12.2003 Original published format: US 525851 P
	[2006/03]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2004111029
	Date:	23.12.2004
	Language:	EN
	[2004/52]
	Type:	A2 Application without search report
	No.:	EP1615913
	Date:	18.01.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.12.2004 takes the place of the publication of the European patent application.
	[2006/03]
Search report(s)	International search report - published on:	EP	17.11.2005
Classification	IPC:	C07D401/12	[2006/03]
	CPC:	C07D401/12 (EP,US); A61P1/04 (EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/03]
Extension states	AL	Not yet paid
	HR	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	VERFAHREN ZUR HERSTELLUNG VON (PYRIDINYL)METHYL SULFINYL-SUBSTITUIERTE BENZIMIDAZOLES UND NEUE CHLORIERTE DERIVATE VON PANTOPRAZOLE	[2007/46]
	English:	PROCESS FOR PREPARING 2-(PYRIDINYL)METHYL SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE	[2006/03]
	French:	PROCEDE DE PREPARATION DE BENZIMIDAZOLES 2- (PYRIDINYL)METHYL SULFINYLE SUBSTITUES ET NOUVEAU DERIVES CHLORURES DE PANTOPRAZOLE	[2007/46]
	Former [2006/03]	VERFAHREN ZUR HERSTELLUNG VON (PYRIDINYL)METHYL]SULFINYL-SUBSTITUIERTE BENZIMIDAZOLES UND NEUE CHLORIERTE DERIVATE VON PANTOPRAZOLE
	Former [2006/03]	PROCEDE DE PREPARATION DE BENZIMIDAZOLES 2- (PYRIDINYL)METHYL]SULFINYLE SUBSTITUES ET NOUVEAU DERIVES CHLORURES DE PANTOPRAZOLE
Entry into regional phase	09.02.2005	National basic fee paid
	09.02.2005	Designation fee(s) paid
	09.02.2005	Examination fee paid
Examination procedure	09.02.2005	Amendment by applicant (claims and/or description)
	09.02.2005	Examination requested [2006/03]
	31.08.2007	Despatch of a communication from the examining division (Time limit: M04)
	10.01.2008	Reply to a communication from the examining division
	30.01.2008	Observations by third parties
	27.05.2008	Despatch of a communication from the examining division (Time limit: M04)
	03.06.2008	Observations by third parties
	15.09.2008	Reply to a communication from the examining division
	13.08.2009	Despatch of a communication from the examining division (Time limit: M04)
	24.12.2009	Application deemed to be withdrawn, date of legal effect [2010/25]
	03.02.2010	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/25]
Fees paid	Renewal fee
	12.06.2006	Renewal fee patent year 03
	14.06.2007	Renewal fee patent year 04
	25.03.2008	Renewal fee patent year 05
	16.06.2009	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]US4758579 (KOHL BERNHARD [DE], et al) [X] 1,8-11,13-15,17,21,23,41-46,59 * example 6 *;
		[XA]WO9947514 (KNOLL AG [DE], et al) [X] 41-46 * example 5 * [A] 1-24,32-40,47-63;
		[XA]WO02062786 (TEVA PHARMA [IL], et al) [X] 41-46 * example 11 * [A] 1-24,32-40,47-63;
		[XA]EP1270555 (ESTEVE QUIMICA SA [ES]) [X] 41-46 * example 4 * [A] 1-24,32-40,47-63;
		[Y]WO03008406 (JANSSEN PHARMACEUTICA NV [BE], et al) [Y] 64-75 * page 8, line 22 - line 26 ** page 10, line 17 - line 25 *;
		[E]WO2004056804 (TEVA PHARMA [IL], et al) [E] 25,26,31 * page 7, line 8 - line 12 * * page 29, line 27 - page 30, line 26; examples 61-64 *;
		[X] - KOHL B ET AL, "(H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl] benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19920320), vol. 35, no. 6, ISSN 0022-2623, pages 1049 - 1057, XP002291720 [X] 1,8-11,13-15,17,21,23,41-49,59,25,31 * page 1055 first column under 'synthesis of sulfoxides by oxidation with aqueous alkaline sodium hypochlorite solution' * * page 1054, second column, under 'preparation of the sodium salt' * DOI: http://dx.doi.org/10.1021/jm00084a010
		[Y] - BADWAN A A ET AL, "PANTOPRAZOLE SODIUM", ANALYTICAL PROFILES OF DRUG SUBSTANCES, (19970124), vol. 29, no. 1, pages 185 - 192, XP008031282 [Y] 64-75 * paragraph [4.4.2] *
	other	US4555518
		EP0997461

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p